Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15023585 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Treatment of Obsessive-Compulsive Disorder
Condition: Obsessive-Compulsive Disorder
Interventions: Drug: olanzapine + fluoxetine;   Drug: placebo + fluoxetine

Indicates status has not been verified in more than two years